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Tuberculosis diagnostics in Fiji: how reliable is culture?
M. Reddy,1 S. Gounder,1 S. A. Reid2
Fiji is a low tuberculosis (TB) burden country, with an estimated incidence of 24 (21–27) cases per 
100 000 population in 2012.1 Sputum smear micros-
copy for acid-fast bacilli (AFB) using Ziehl-Neelsen 
(ZN) staining and sample culture using Ogawa me-
dium are the current standard diagnostic methods in 
Fiji, where AFB microscopy is the routine screening 
method for all suspected cases of TB. Ogawa cultures 
require up to 8 weeks to yield a result. Sputum smear 
microscopy is a simple, inexpensive technique that 
enables the rapid detection of AFB. Culture is the ref-
erence standard in the TB diagnostic algorithm for 
evaluating patients with negative smears, as it in-
creases sensitivity and enables earlier case detection. 
Culture also provides material for the identification of 
mycobacterial species and their drug susceptibility 
profiles, which is important in patients with suspected 
drug-resistant TB.2 Recent reviews of TB diagnosis in 
Fiji identified issues affecting culture positivity rates, 
including culture degradation and contamination, 
which have a negative impact on the accuracy of TB 
diagnosis and effective TB control.3,4 The above issues 
have also been identified in other countries.5.A pro-
gramme review in 2011 showed that up to 13–18% of 
cultures were contaminated and that attempts to cul-
ture mycobacteria from 12% of smear-positive speci-
mens had failed.4 The review recommended that the 
reasons for the high contamination and high negative 
culture rate among smear-positive samples should be 
investigated to enable corrective measures to be 
implemented.
The main objectives of the present study were to 
investigate the level of agreement between culture and 
AFB microscopy results, and to determine the culture 
contamination rate and associated factors.
METHODOLOGY
Setting
This retrospective study was conducted at the Daulako 
Mycobacterium Reference Laboratory (DMRL), Suva, 
Fiji, the only TB reference laboratory in Fiji. TB treat-
ment centres performing AFB microscopy are located 
in each of the three major divisions of Fiji, the Cen-
tral, Northern and Western Divisions. Samples from 
four TB microscopy centres are processed for TB cul-
ture at the DMRL. An average of 2000 specimens are 
cultured for TB from the three divisions each year. 
Specimens referred for culture include sputum, ascitic 
fluid, pleural fluid, cerebral spinal fluid, pus, tissue, 
bronchial washing and lavage, stool and urine. All 
specimens undergo AFB microscopy and ZN staining 
before referral. Smear-positive samples and good qual-
ity smear-negative samples are referred for TB culture 
on Ogawa media at the DMRL.
Participants
All specimens referred from the three divisions of Fiji 
for TB culture from January 2010 to December 2012 
were included in the study.
Data variables, data collection instrument
Data for each variable were extracted from the TB cul-
ture register held at the DMRL into a structured pro-
forma. Exposure variables for each specimen included 
referring division, TB culture registration number, 
type of specimens submitted, AFB smear status and 
age of the sample based on the date of collection and 
date of processing. Outcome variables in this study are 
the agreement between culture and smear result and 
presence of contamination during the period of 
incubation.
Analysis and statistics
All data collected were entered into EpiData Version 
3.1 (EpiData Association, Odense, Denmark). The 
proportion and 95% confidence interval (CI) for 
each determinant associated with each culture out-
come category was calculated. The statistical signifi-
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Settings: Acid-fast bacilli (AFB) smear microscopy and 
Mycobacterium tuberculosis culture are the first-line diag-
nostic tests for tuberculosis (TB). The contamination of 
TB cultures significantly reduces the reliability of TB 
diagnosis.
Objective: To investigate factors associated with TB 
culture contamination in Fiji, and the relative diagnostic 
performance of culture compared to microscopy.
Design: All tests performed at the Daulakao Mycobac-
terium Reference Laboratory (DMRL) in Fiji from 2010 to 
2012 were reviewed. Study variables included AFB smear 
and TB culture results, age and type of specimen, 
referring TB testing centre and patient age.
Results: Of 5708 specimens reviewed, 70% had both 
AFB smear and culture results recorded; 421 specimens 
were contaminated; 2.7% of specimens were either de-
graded or had no result recorded. There was moderate 
agreement (κ = 0.577) between the two tests. Culture 
was more likely to be positive at higher AFB smear scores. 
Culture contamination was associated with distance from 
the DMRL, sample age and operator-associated factors.
Conclusion: Increases in the speed of referral from TB 
testing centres or the addition of preservatives to sputum 
specimens may results in less culture contamination. The 
planned introduction of liquid culture techniques in com-
bination with culture on Ogawa media is likely to in-
crease the sensitivity of TB diagnosis in Fiji.
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cance of any difference was determined using the χ2 
test, with 95%CI. The sensitivity and specificity of 
AFB microscopy as regards culture and their binomial 
95%CIs were calculated using WinEpiscope 2.0 (Agri-
cultural University, Wageningen, The Netherlands; 
www.clive.ed.ac.uk/winepiscope/ ) using the culture 
results as the gold standard. The agreement between 
culture and AFB microscopy was also calculated us-
ing WinEpiscope.
Ethics
Ethics approval was obtained from the Fiji National 
Research Ethics Committee, Suva, Fiji, and the Interna-
tional Union Against Tuberculosis and Lung Disease 
Ethics Advisory Group, Paris, France.
RESULTS
AFB microscopy and culture results were available for 
3998 of the 5708 samples tested between 2010 and 
2012 (Figure 1); 630 (15.8%) specimens were 
smear-positive and 434 (10.8%) were culture-positive. 
However, 98/3368 (2.9%) smear-negative specimens 
were culture-positive, and 294/630 (46.7%) smear-pos-
itive specimens were culture-negative. There was mod-
erate agreement (κ = 0.577) between the two diagnos-
tic methods. The overall sensitivity and specificity of 
AFB smear microscopy using culture as the reference 
standard was respectively 77% (95%CI 73–81) and 
92% (95%CI 90–93).
The culture contamination rate was significantly 
lower in samples from the Western Division compared 
to the Central and Northern Divisions, and signifi-
cantly higher in the Northern than in the Central Di-
vision (P  0.05) (Table 1). Samples were more likely to 
be contaminated 30 days after collection (P = 0.006). 
Finally, there were significantly higher rates of con-
tamination in samples collected in 2011 and 2012 
than in 2010 (P  0.05) (Figure 2). The culture con-
tamination rate of AFB smear-positive samples was sig-
nificantly higher than AFB smear-negative samples (P 
 0.05), and was significantly higher in AFB 3+ sam-
ples than in other positivity categories (P  0.05) (Fig-
ure 3). There was no significant difference in contami-
nation rate in samples from patients in different age 
groups and in the different types of specimens.
DISCUSSION
This is the first study to evaluate the rate and factors 
associated with contamination of diagnostic TB cul-
tures in Fiji. Only 70% of the records from specimens 
submitted to the DMRL for TB culture were valid for 
use in this study; the most significant reason for exclu-
sion was the absence of AFB smear results. This is an 
important omission from the laboratory records, as 
AFB smear microscopy is the first-line diagnostic pro-
cedure for TB in Fiji. These omissions most likely occur 
when specimens are initially submitted to or during re-
ferral from the divisional laboratories that perform 
AFB smear microscopy. This suggests that a review of 
the implementation of specimen submission and/or 
referral protocols is required to ensure that data re-
cording is standardised. It may also be worth consider-
ing introducing microscopy on sediment before cul-
ture inoculation, which may provide an alternative 
mechanism for capturing AFB smear results. Results 
show that a significant number of samples are AFB 
smear-positive but culture-negative. The bacterial load 
in a specimen is an important factor in determining 
the culture positivity rate. This is illustrated in this 
study by the increasing positivity rate in AFB smear 
grades of more than 3+. A recent study revealed that 
most culture failures from smear-positive samples were 
from patients in the intensive phase of treatment for 
TB.6
Culture quality cannot only be determined by eval-
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FIGURE 1 Flow diagram of the analysis of the results of smear microscopy and 
Ogawa culture in the detection of Mycobacterium tuberculosis for all samples submit-
ted to the Daulako Mycobacterium Reference Laboratory, Suva, Fiji, 2010–2012.
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uating culture contamination. Factors such as samples from pa-
tients on treatment, reporting of false-positive smears and exces-
sive decontamination of specimens while processing should also 
be considered; however, as it could not be evaluated in this study 
due to lack of data, this is a major study limitation. The sensitiv-
ity of AFB smear microscopy is also dependent on the type and 
quality of specimen.7 The sensitivity of smear in comparison with 
the reference standard in this study was a little lower than ob-
served in other studies.8–10 It is difficult to interpret this observa-
tion due to the different culture techniques used in each study. 
The World Health Organization (WHO) now recommends ex-
panded use of liquid culture systems in resource-constrained set-
tings.11.Studies have shown that the recovery rate of mycobacteria 
and overall TB case detection rates can be improved if a solid cul-
ture medium, such as Ogawa, is used in combination with Löwen-
stein-Jensen (LJ) liquid culture medium and/or the Mycobacte-
rium Growth Indicator Tube (MGIT™; BD, Sparks, MD, USA).12–14
The rate of culture contamination differed depending on the 
origin of the specimen in Fiji. The highest contamination rate 
was observed in specimens from the Northern Division, which is 
a separate island some distance from Suva, where the DMRL is lo-
cated, requiring transport by air freight. Samples are routinely 
batched and transported each week (or less frequently) to reduce 
costs associated with transportation of hazardous materials. This 
results in a higher sample age than that of samples from the Cen-
tral and Western Divisions, which are on the main island and 
connected to Suva by road. The introduction of a cold chain for 
sample transportation could reduce the contamination rate.
The observed change in contamination rate over different 
years is most likely due to the rotation of inexperienced labora-
tory staff to perform TB culture at the DMRL, when workloads 
were high or when regular staff were absent. Care must be taken 
to ensure that staff in the DMRL are adequately trained before 
they perform culture; this includes instruction in culture practices 
and standard operating procedures with regard to sample han-
dling and data entry. Any changes to these protocols should be 
communicated directly to staff involved in microbiological cul-
ture in general, and more specifically to those deployed to per-
form TB culture. Culture contamination reduces the proportion 
of interpretable results and diminishes the diagnostic value of cul-
ture systems.
Studies have shown varying contamination rates in different 
TB culture systems.15–18 Recent studies showed that an increase in 
storage time of up to 7 days at room temperature resulted in a re-
duced rate of recovery of Mycobacterium tuberculosis and rising 
contamination rates.19–21 This is also reflected in the present 
study, where the contamination rate gradually increased with 
sample age. Detection of growth of M. tuberculosis from samples 
inoculated onto solid medium such as Ogawa may take 6–8 
weeks, leading to delays in treatment. The WHO recommends 
that specimens be collected from remote areas and transported to 
reference laboratory without delay.22 It is also recommended that 
when specimens are likely to be exposed to room temperature for 
48 h, an equal volume of either 0.6% cetylpyridinium bromide 
or 1% cetylpyridinium chloride be added to homogenise and de-
TABLE 1 Factors associated with the contamination of Ogawa 










 Central/Eastern 4517 318 (7.0)
 Northern 835 97 (11.6)
 Western 356 6 (1.7)
Age group, years
 0–14 435 31 (7.1)
 15–24 682 62 (9.1)
 25–34 867 64 (7.4)
 34–44 754 54 (7.2)
 45–54 875 56 (6.4)
 55–64 852 55 (6.5)
 65 825 76 (9.2)
 Unknown 419 23 (5.5)
Specimen type
 Sputum 5346 386 (7.2)
 Ascitic fluid 43 2 (4.7)
 Pleural fluid 143 13 (9.1)
 CSF 20 0
 Pus 31 3 (9.7)
 Tissue 2 0
 Lavage/washing 123 17 (13.8)
AFB smear
 Positive 706 51 (7.2)
 Negative 3698 217 (5.9)
 Status unknown 1304 153 (11.7)
Sample age, days* 
 0–9 397 24 (6)
 10–20 553 33 (6)
 21–30 311 24 (8)
 30 305 37 (12)
* Calculated only for 1566 specimens that had a recorded date of collection.
CSF = cerebrospinal fluid; AFB = acid-fast bacilli.
FIGURE 2 Proportion of contaminated Ogawa cultures for 
Mycobacterium tuberculosis, Fiji, 2010–2012.
FIGURE 3 Proportion of contaminated Ogawa cultures for 
Mycobacterium tuberculosis categorised based on positive AFB 
smear results, Fiji, 2010–2012. AFB = acid-fast bacilli.
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contaminate samples before they are sent to the reference labora-
tory.21,23 A recent study showed that culture contamination rates 
are significantly reduced if preservative is added to specimens be-
fore shipping.19
The contamination of culture due to oral-pharyngeal flora is 
another possible interpretation of our study findings. It was ob-
served that contamination was more likely in smear-positive than 
in smear-negative specimens. Recent studies have shown that the 
use of an oral antimicrobial mouth rinse before sample collection 
significantly reduces TB culture contamination.24,25 The contami-
nation rates in Fiji might thus be reduced if the use of an inex-
pensive oral mouth wash such as chlorohexidine was incorpo-
rated into standard sputum collection protocols.
An important limitation of this study was that it was a retro-
spective review of laboratory records, and there was thus no addi-
tional means of validating the data used in the study. Future stud-
ies could be improved by collecting additional data on samples 
from patients on anti-tuberculosis treatment from the registers of 
the referring laboratories. The information available did not per-
mit an evaluation of the association between individual operators 
and culture contamination.
CONCLUSION
Sample referral systems should be improved to enhance data col-
lection and improve specimen collection and handling to main-
tain the viability of M. tuberculosis while reducing contamination. 
Adoption of liquid culture systems by the Fiji Ministry of Health 
is planned in the context of a comprehensive and detailed coun-
try plan for TB laboratory capacity strengthening. A review of TB 
culture techniques and the incorporation of methods such as LJ 
and MGIT, together with current practices, will boost the sensitiv-
ity of culture. However, the current issues with aged samples for 
culture may become more challenging with the sensitivity of cul-
ture on MGIT. A further study will be required to compare con-
tamination rates and culture sensitivity after implementation of 
liquid culture methods. Improved management and increases in 
the number of trained staff available to perform TB culture may 
also reduce the rate of contamination. Adopting the use of preser-
vatives to decontaminate referred specimens for TB culture and 
the use of mouth wash before sputum collection may reduce the 
risk of contamination due to the presence of normal flora.
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Contexte  :  L’examen microscopique de crachats à la recherche de 
bacilles acido-alcoolo résistants (AFB) et la culture de Mycobacterium 
tuberculosis sont des examens de première intention dans le 
diagnostic de la tuberculose (TB). La contamination des cultures de 
TB réduit la fiabilité du diagnostic.
Objectif : Examiner les facteurs associés à la contamination des 
cultures de TB aux Fidji et les performances relatives de la culture et 
de l’AFB.
Méthodes  :  Tous les examens réalisés au Laboratoire de Référence 
des Mycobacterium de Daulakao aux Fidji de 2010 à 2012 ont été 
inclus. Les variables comprenaient les résultats de l’AFB et de la 
culture, l’âge et le type de spécimen, le centre d’examen ayant 
envoyé l’échantillon et l’âge du patient.
Résultats : Des 5708 spécimens enregistrés, 70% comprenaient à la 
fois les résultats du frottis AFB et de la culture. Une contamination est 
survenue dans 421 spécimens et 2,7% d’entre eux étaient soit 
dégradés, soit sans résultats. L’accord entre les deux tests était 
modéré (κ = 0,577). La culture avait plus de chances d’être positive 
quand le score du frottis AFB était plus élevé. La contamination de la 
culture était associée à la distance par rapport au laboratoire de 
référence, à l’âge de l’échantillon et à des facteurs liés à l’opérateur.
Conclusion  :  Une plus grande rapidité de transmission des 
échantillons de crachats depuis le centre d’examens anti-tuberculeux 
ou l’adjonction de conservateurs aux spécimens de crachats pourrait 
amener une diminution du taux de contamination des cultures. 
L’introduction de techniques de cultures liquides combinée à la 
culture sur milieu Ogawa augmentera la sensibilité du diagnostic de 
la TB aux Fidji.
Marco de Referencia: El examen microscópico en busca de bacilos 
acidorresistentes (AFB) y el cultivo de Mycobacterium tuberculosis 
constituyen las pruebas de elección en el diagnóstico de la 
tuberculosis (TB). Sin embargo, la contaminación de los cultivos 
disminuye la fiabilidad del diagnóstico.
Objetivo: Investigar los factores que se asocian con la contaminación 
de los cultivos de M. tuberculosis en Fiji y el desempeño relativo del 
cultivo y la AFB.
Metodos: Se incluyeron en el estudio todas las pruebas realizadas en 
el Daulako Mycobacterium Reference Laboratory (DMRL) en Fiji del 
2010 al 2012. Las variables examinadas fueron el resultado de la AFB 
y del cultivo, el tipo de muestra, el lapso transcurrido desde la 
recogida de la muestra hasta la prueba, el centro de TB que la remitió 
y la edad del paciente.
Resultados: Se registraron 5708 muestras; el 70% de los casos 
comportaba el resultado de la AFB y el cultivo. Se contaminaron 421 
muestras y 2,7% de las muestras se degradaron o carecían de 
resultado. Se observó una concordancia moderada entre ambas 
pruebas (κ = 0,577). El cultivo fue con mayor frecuencia positivo en 
las muestras que presentaban una alta puntuación de AFB. La 
contaminación del cultivo se asoció con la distancia entre el centro 
de origen y el DMRL, el lapso transcurrido desde la recogida de la 
muestra y otros factores propios del operador.
Conclusión: Al aumentar la velocidad de remisión de las muestras 
desde el centro de pruebas de TB o agregar conservantes a las 
muestras de esputo se puede disminuir la tasa de contaminación de 
los cultivos. La introducción de las técnicas de cultivo en medio 
líquido, además de la utilización del medio de Ogawa, permitirá 
mejorar la sensibilidad del diagnóstico de la TB en Fiji.  
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